European Society for Radiotherapy and Oncology (ESTRO) shared a post on X:
“TipsRO Young Researcher Award: check out this study awarded at ESTRO24, in which MRlinac vs. HDR brachytherapy for GTV boost was compared, with a focus on patient-reported quality of life and acute toxicity profiles.”
Read further.
Source: ESTRO/X